Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory

Hippocampus

Volumn 25, Issue 8, 2015, Pages 939-951

  Moodley, Kuven ^a   Minati, Ludovico ^a,b   Contarino, Valeria ^b   Prioni, Sara ^b   Wood, Ruth ^a   Cooper, Rebecca ^c   D'Incerti, Ludovico ^b   Tagliavini, Fabrizio ^b   Chan, Dennis ^a  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c Worthing Hospital   (United Kingdom)

Author keywords

Alzheimer's disease; Hippocampus; Mild cognitive impairment; Precuneus; Spatial memory

Indexed keywords

4 MOUNTAINS TEST; ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MEMORY ASSESSMENT; MILD COGNITIVE IMPAIRMENT; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPATIAL MEMORY; TASK PERFORMANCE; AGED; ANALYSIS OF VARIANCE; CLINICAL TRIAL; DEPTH PERCEPTION; GREAT BRITAIN; IMAGE PROCESSING; ITALY; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GREAT BRITAIN; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ITALY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; ROC CURVE; SPACE PERCEPTION; SPATIAL MEMORY; STATISTICS AS TOPIC;

EID: 84937074363     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22417     Document Type: Article

References (62)

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust JM, Petersen RC, Snyder PJ, Carillo MC, Thies B, Phelps CH . 2011. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:270-279.
2. Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli P. 2005. The frontal assessment battery (FAB): Normative values in an Italian population sample. Neurol Sci 26:108-116.
3. Arriagada PV, Marzloff K, Hyman BT. 1992. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42:1681-1688.
4. Benton A, Hamsher K, Sivan A. 1994. Multilingual Aphasia Examination, 3rd ed. San Antonio, TX: Psychological Corporation.
5. Bird CM, Chan D, Hartley T, Pijnenburg YA, Rossor MN, Burgess N. 2010. Topographical short-term memory differentiates Alzheimer's disease from frontotemporal lobar degeneration. Hippocampus 20:1154-1169.
6. Blackburn HL, Benton AL. 1957. Revised administration and scoring of the digit span test. J Consult Psychol 21:139-143.
7. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
8. Buckner RL, Andrews-Hanna JR, Schacter DL. 2008. The brain's default network: Anatomy, function, and relevance to disease. Ann New York Acad Sci 1124:1-38.
9. Burgess N, Maguire EA, Spiers HJ, O'Keefe J. 2001. Temporoparietal and prefrontal network for retrieving the spatial context of lifelike events. Neuroimage 14:439-453.
10. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. 2002. Rey-Osterreith complex figure: Normative values in an Italian population sample. Neurol Sci 22:443-447.
11. Cavanna A, Trimble M. 2006. The precuneus: A review of its functional anatomy and behavioural correlates. Brain 129:564-583.
12. Chapman RM, Mapstone M, McCrary JW, Gardner MN, Porsteinsson A, Sandoval TC, Guillily MD, Degrush E, Reilly LA . 2011. Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods. J Clin Exp Neuropsychol 33:187-199.
13. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. 2006. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968-980.
14. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW. 2001. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 71:441-447.
15. Dubois B, Feldman HH, Jacova C, Cummings CL, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P. 2010. Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9:1118-1127.
16. Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR, Feldman HH, Bokde AL, Alexander GE, Scheltens P, Vellas B, Dubois B, Weiner M, Hampel H . 2012. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging 30:1203-1214.
17. Fennema-Notestine C, Hagler DJ, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM, Alzheimer's Disease Neuroimaging Initiative. 2009. Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp 30:3238-3253.
18. Fischl B. 2012. FreeSurfer. Neuroimage 62:774-781.
19. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
20. Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. 2002. Paired associate performance in the early detection of DAT. J Int Neuropsychol Soc 8:58-71.
21. Gainotti G, Quaranta D, Vita MG, Marra C. 2014. Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 38:481-495.
22. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. 1996. Trail making test: Normative values from 287 normal adult controls. Ital J Neurol Sci 17:305-309.
23. Greicius MD, Krasnow B, Reiss AL, Menon V. 2003. Functional connectivity in the resting brain: A network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 100:253-258.
24. Greicius MD, Srivastava G, Reiss AL, Menon V. 2004. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci USA 101:4637-4642.
25. Hämäläinen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, Huuskonen J, Kivipelto M, Hanninen T, Tapiola M, Verhanen M, Hallikainen M, Helkala EL, Nissinen A, Vanninen R, Soininen H . 2007. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage 37:1122-1131.
26. Hartley T, Harlow R. 2012. An association between human hippocampal volume and topographical memory in healthy young adults. Front Hum Neurosci 6:338.
27. Hartley T, Bird CM, Chan D, Cipolotti L, Husain M, Vargha-Khadem F, et al. 2007. The hippocampus is required for short-term topographical memory in humans. Hippocampus 17:34-48.
28. Iaria G, Chen J-K, Guariglia C, Ptito A, Petrides M. 2007. Retrosplenial and hippocampal brain regions in human navigation: Complementary functional contributions to the formation and use of cognitive maps. Eur J Neurosci 25:890-899.
29. James M, Warrington EK. 1991. The Visual Object and Space Perception Battery. Thames Valley Test Company.
30. Maguire EA, Burgess N, Donnett JG, Frackowiak RS, Frith CD, O'Keefe J. 1998. Knowing where and getting there: A human navigation network. Science 280:921-924.
31. Maguire EA, Burgess N, O'Keefe J. 1999. Human spatial navigation: Cognitive maps, sexual dimorphism, and neural substrates. Curr Opin Neurobiol 9:171-177.
32. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Korosheltz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH . 2011. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263-269.
33. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. 2006. The Addenbrooke's Cognitive Examination Revised (ACE-R): A brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078-1085.
34. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L . 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-786.
35. Morey RA, Petty CM, Xu Y, Pannu Hayes J, Wagner HR II, Lewis DV, et al. 2009. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. Neuroimage 45:855-866.
36. Moroney JT, Baqiella E, Desmond DW, Hachinski VC, Molska PK, Brun A, Fischer P, Erkinjuntti T, Rosen W, Paik MC, Tatemichi TK . 1997. Meta-analysis of the Hachinski Ischaemic score in pathologically verified dementias. Neurology 49; 1096-1105.
37. Morris JC. 1993. The clinical dementia rating (CDR): Current version and scoring rules. Neurology 43:2412-2414.
38. Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ, Scheltens P, Blankenstein MA . 2010. Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem 56:248-253.
39. Mulder ER, de Jong RA, Knol DL, van Schijndel RA, Cover KS, Visser PJ, Barkhof F, Vrenken H, Alzheimer's Disease Neuroimaging Initiative. 2014. Hippocampal volume change measurement: Quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST. Neuroimage 92:169-181.
40. Nelson H, Willison J. 1991. National Adult Reading Test Manual (NART). Windsor, UK: NFER-Nelson.
41. Novelli G, Papagno C, Capitani E, Laiacona M, et al. 1986. Tre test clinici di memoriaverbale a lungotermine: Taraturasusoggettinormali. Arch Psicol Neurol Psichiatr 47:278-296.
42. O'Keefe J, Dostrovsky J. 1971. The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. Brain Res 34:171-175.
43. O'Keefe J, Nadel L. 1978. The Hippocampus as a Cognitive map. Oxford, UK: Oxford University Press.
44. Patenaude BB, Smith SMS, Kennedy DND, Jenkinson MM. 2011. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907-922.
45. Pengas G, Patterson K, Arnold RJ, Bird CM, Burgess N, Nestor PJ. 2010. Lost and found: Bespoke memory testing for Alzheimer's disease and semantic dementia. J Alzheimers Dis 21:1347-1365.
46. Pengas G, Williams GB, Acosta-Cabronero J, Ash TWJ, Hong YT, Izquierdo-Garcia D, Fryer TD, Hodges JR, Nestor PJ . 2012. The relationship of topographical memory performance to regional neurodegeneration in Alzheimer's disease. Front Aging Neurosci 4:17.
47. Petersen RC. 2004. Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183-194.
48. Price JL, McKeel DW, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesberry WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC . 2009. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30:1026-1036.
49. Reitan RM. 1958. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271-276.
50. Rey A. 1941. L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 28:21.
51. Rombouts SA, Barkhof F, Goekoop R, Stam CJ, Scheltens P. 2005. Altered resting state networks in mild cognitive impairment and mild disease: An fMRI study. Hum Brain Mapp 26:231-239.
52. Sachdev P, Kalaria R, O'Brien J, Skooq I, Alladi S, Black SE et al. 2014. Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Dis Assoc Disord 28:206-218.
53. Sánchez-Benavides G, Gómez-Ansón B, Sainz A, Vives Y, Delfino M, Peña-Casanova J. 2010. Manual validation of FreeSurfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer Disease subjects. Psychiatry Res 181:219-225.
54. Selemon LD, Goldman-Rakic PS. 1988. Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: Evidence for a distributed neural network subserving spatially guided behavior. J Neurosci 8:4049-4068.
55. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ, Alzheimer's Disease Neuroimaging Initiative. 2009. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65:403-413.
56. Spinnler H, Tognoni G. 1987. Standardizzazione e taratura di test Neuropsicologici. Ital J Neurol Sci 8 (suppl 6):1-20.
57. Thal DR, Rüb U, Orantes M, Braak H. 2002. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800.
58. Tombaugh TN, Kozak J, Rees L. 1999. Normative data stratified by age and education for two measures of verbal fluency: FAS and Animal Naming. Arch Clin Neuropsychol 14:167-177.
59. Van der Elst W, van Boxtel MPJ, van Breukelen GJP, Jolles J. 2005. Rey's verbal learning test: Normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 2005; 11:290-302.
60. Vincent JL, Snyder AZ, Fox MD, Shannon BJ, Andrews JR, Raichle ME, et al. 2006. Coherent spontaneous activity identifies a hippocampal-parietal memory network. J Neurophysiol 96:3517-3531.
61. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R et al. 2013. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822-838.
62. Wechsler D. 1945. A standardized memory scale for clinical use. J Psychol 19:87-95.